Neurovascular consequences of non-pulsatile flow from left ventricular assist devices
Neurovascular consequences of non-pulsatile flow from left ventricular assist devices
批准号:
10367076
负责人:
Joshua Zebadiah Willey
金额:
$59.97万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-01-01 至 2026-12-31
关键词:
Adverse eventAgeAnatomyAngiographyAnticoagulantsAnticoagulationBiologicalBiological MarkersBlood - brain barrier anatomyBlood PressureBlood VesselsBlood flowBlood-Retinal BarrierBrainBrain hemorrhageCardiac OutputCause of DeathCerebral hemisphere hemorrhageCerebrovascular CirculationCerebrumClinicalCognitionCognitiveCongestive Heart FailureDevice DesignsDiseaseEndotheliumEventExercise ToleranceFunctional disorderGastrointestinal HemorrhageGeneral PopulationGenerationsGoalsHeart TransplantationHemorrhageHomeostasisHumanHypertensionInterdisciplinary StudyInvestigationIschemic StrokeMeasuresMicrocirculationMorbidity - disease rateNeuraxisNeuropsychological TestsNeuropsychologyObservational StudyOperative Surgical ProceduresOptical Coherence TomographyOutcomeParticipantPathologic ProcessesPatientsPatternPermeabilityPhysiologicalPhysiologyPlayPopulationPrevalencePublic HealthReperfusion InjuryResearchRetinaRisk FactorsRoleSecondary toSerumStructureTimeTransplantationarterial stiffnessarterioleblood-brain barrier disruptionblood-brain barrier permeabilizationcerebrovascularclinically significantcognitive changedesignendothelial dysfunctionimplantationimprovedin vivoin vivo imagingindexingindividualized medicineleft ventricular assist devicelifetime riskmechanical circulatory supportmortalityneurovascularneurovascular unitretinal imagingrisk stratificationstroke therapy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary:
This project will be an observational study with the primary goal to examine the consequences of non-pulsatile
flow under continuous flow left ventricular assisted devices (CF-LVAD) on the cerebral circulation. The public
health burden from congestive heart failure (CHF) is substantial and few treatment options are available to those
patients at the end-stage. Unfortunately, cardiac transplantation is not widely available and many of these
patients rely on left ventricular assist devices for circulatory support. The newest generation devices are
designed for durability and therefore deliver non-pulsatile flow. Despite improvements in CHF mortality, CF-
LVAD is associated with multiple complications that are hypothesized to originate from the impact of non-pulsatile
flow on arterial endothelium, notably gastrointestinal bleeding, and poor gains in exercise tolerance. CF-LVAD
patients develop unusually high rates of ischemic stroke with hemorrhagic transformation (ISHT), one of the
leading causes of death in these patients. ISHT in the general population results from microcirculatory
dysfunction with disruption of the blood brain barrier (BBB) and cerebral endothelium. The impact of non-pulsatile
flow on the BBB and cerebral endothelium has not yet been studied in human CF-LVAD patients, in part due to
the lack of markers specific to the cerebral circulation. In aim 1a we will perform transcranial Doppler (TCD)
before and after CF-LVAD implantation to measure the breath holding index as a physiological marker of cerebral
autoregulation an important function of cerebral endothelium. In aim 1b we will examine the impact of non-
pulsatile flow on the blood retina barrier (anatomically similar to the BBB) with optical coherence tomography
angiography and retinal doppler. In aim 2 we will examine changes in cognition in CF-LVAD participants before
and after surgery and versus controls. The overall goals of this proposal will be to identify physiological and
functional changes which occur in the cerebral circulation under non-pulsatile flow which will allow for improved
risk stratification and tailored treatment approaches in the application of CF-LVAD in end-stage CHF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurovascular Consequences of Non-Pulsatile Flow from Left Ventricular Assist Devices
-
批准号:10544052
-
项目类别:
-
资助金额:$51.15万
-
财政年份:2022
-
负责人:Joshua Zebadiah Willey
-
依托单位:
Neuro-vascular Disease as a Cause of Impaired Mobility
-
批准号:8189900
-
项目类别:
-
资助金额:$17.51万
-
财政年份:2011
-
负责人:Joshua Zebadiah Willey
-
依托单位:
Neuro-vascular Disease as a Cause of Impaired Mobility
-
批准号:8304918
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2011
-
负责人:Joshua Zebadiah Willey
-
依托单位:
Neuro-vascular Disease as a Cause of Impaired Mobility
-
批准号:8521909
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2011
-
负责人:Joshua Zebadiah Willey
-
依托单位:
Neuro-vascular Disease as a Cause of Impaired Mobility
-
批准号:8704364
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2011
-
负责人:Joshua Zebadiah Willey
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: